Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental parasitology

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exppara.2009.02.010PMID 19249301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alphavirus Replicon Particles Are Highly Immunogenic in the Murine Malaria Model by Homologous or Heterologous Immunization

  2008cited by this paper
• Heterologous Protein Expression Is Enhanced by Harmonizing the Codon Usage Frequencies of the Target Gene with those of the Expression Host

  2008cited by this paper
• Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.

  2007cited by this paper
• Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.

  2007cited by this paper
• Improvement in Yield and Purity of a Recombinant Malaria Vaccine Candidate Based on the Receptor-Binding Domain of Plasmodium vivax Duffy Binding Protein by Codon Optimization

  2006cited by this paper
• Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.

  2006cited by this paper
• A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.

  2006cited by this paper
• Protein disulfide isomerase assisted protein folding in malaria parasites.

  2006cited by this paper
• Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length Plasmodium falciparum Circumsporozoite Protein

  2006cited by this paper
• Gene-based vaccines: recent technical and clinical advances.

  2006cited by this paper
• Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B

  2005cited by this paper
• C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences.

  2005cited by this paper
• Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites

  2005cited by this paper
• Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.

  2004cited by this paper
• A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases.

  2004cited by this paper
• Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.

  2004cited by this paper
• DNA/MVA Vaccine for HIV Type 1: Effects of Codon-Optimization and the Expression of Aggregates or Virus-Like Particles on the Immunogenicity of the DNA Prime

  2004cited by this paper
• Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization

  2004cited by this paper
• Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli

  2004cited by this paper
• Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF

  2004cited by this paper
• Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.

  2004cited by this paper
• Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene

  2004cited by this paper
• Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen

  2003cited by this paper
• Effect of Codon Optimization on Expression Levels of a Functionally Folded Malaria Vaccine Candidate in Prokaryotic and Eukaryotic Expression Systems

  2003cited by this paper
• Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

  2003cited by this paper
• Making sense of mass destruction: quantitating MHC class I antigen presentation

  2003cited by this paper
• Quantitating protein synthesis, degradation, and endogenous antigen processing.

  2003cited by this paper
• DNA vaccination: the answer to stable, protective T-cell memory?

  2003cited by this paper
• Gene Vaccines

  2003cited by this paper
• Safety, Tolerability, and Lack of Antibody Responses After Administration of a PfCSP DNA Malaria Vaccine via Needle or Needle-Free Jet Injection, and Comparison of Intramuscular and Combination Intramuscular/Intradermal Routes

  2002cited by this paper
• Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14

  2002cited by this paper
• Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13

  2002cited by this paper
• Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

  2002cited by this paper
• Multiple Effects of Codon Usage Optimization on Expression and Immunogenicity of DNA Candidate Vaccines Encoding the Human Immunodeficiency Virus Type 1 Gag Protein

  2001cited by this paper
• Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy.

  2001cited by this paper
• Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

  2001cited by this paper
• Codon Optimization of Gene Fragments EncodingPlasmodium falciparum Merzoite Proteins Enhances DNA Vaccine Protein Expression and Immunogenicity in Mice

  2001cited by this paper
• A Subdominant CD8+ Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoeliiCircumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture

  2000cited by this paper
• The Complexity of Protective Immunity Against Liver-Stage Malaria1 2

  2000cited by this paper
• Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene

  2000cited by this paper
• IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.

  1999cited by this paper
• Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms.

  1999cited by this paper
• Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.

  1999cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage

  1998cited by this paper
• Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.

  1997cited by this paper
• An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.

  1997cited by this paper
• Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

  1996cited by this paper
• Immune deviation: A historical perspective *

  1996cited by this paper
• Identification and Characterization of the Protective Hepatocyte Erythrocyte Protein 17 kDa Gene of Plasmodium yoelii, homolog of Plasmodium falciparum Exported Protein 1*

  1996cited by this paper
• Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

  1994cited by this paper
• Purification and characterization of dihydrofolate reductase of Plasmodium falciparum expressed by a synthetic gene in Escherichia coli.

  1994cited by this paper
• Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.

  1994cited by this paper
• In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.

  1991cited by this paper
• Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

  1990cited by this paper
• Peptide-primed CD4+ cells and malaria sporozoites.

  1990cited by this paper
• Codon usage in Plasmodium falciparum.

  1988cited by this paper
• CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

  1988cited by this paper
• Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines.

  1987cited by this paper
• Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

  1987cited by this paper
• The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications.

  1987cited by this paper
• Codon usage and tRNA content in unicellular and multicellular organisms.

  1985cited by this paper
• Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

  1984cited by this paper
• The genome of Plasmodium falciparum. I: DNA base composition.

  1982cited by this paper
• Codon usage in bacteria: correlation with gene expressivity.

  1982cited by this paper
• Codon selection in yeast.

  1982cited by this paper
• The Relationship Between Humoral and Cell‐Mediated Immunity

  1972cited by this paper
• Gamma-Globulin and Acquired Immunity to Human Malaria

  1961cited by this paper

• DNA Vaccine Technologies: Design and Delivery

  2025cites this paper
• Malaria Vaccines: From the Past towards the mRNA Vaccine Era

  2023cites this paper
• Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South

  2023cites this paper
• Population Genetic Analyses Inferred a Limited Genetic Diversity in the Pvama-1 of Plasmodium Vivax Isolates from Khyber Pakhtunkhwa Regions of Pakistan

  2022cites this paper
• Population genetic analyses inferred a limited genetic diversity across the pvama-1 DI domain among Plasmodium vivax isolates from Khyber Pakhtunkhwa regions of Pakistan

  2022cites this paper
• New viral vectors for infectious diseases and cancer.

  2020cites this paper
• Genetic engineering approaches to the development of modern therapeutics

  2020cites this paper
• Deciphering host immunity to malaria using systems immunology

  2020cites this paper
• Antigenicity and immune correlate assessment of seven Plasmodium falciparum antigens in a longitudinal infant cohort from northern Ghana

  2019cites this paper
• Analysis of Apical Membrane Antigen (AMA)-1 characteristics using bioinformatics tools in order to vaccine design against Plasmodium vivax.

  2019cites this paper
• Molecular Adjuvants for DNA Vaccines.

  2017cites this paper
• Molecular Adjuvants for DNA

  2016cites this paper
• Molecular mechanisms for enhanced DNA vaccine immunogenicity

  2016cites this paper
• Functional, biochemical and structural analyses of Plasmodium falciparum pyruvate dehydrogenase complex

  2014cites this paper
• Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA

  2013cites this paper
• Cloning, expression, and immunocharacterization of surface protein containing an altered thrombospondin repeat domain (SPATR) from Plasmodium knowlesi

  2013cites this paper
• The future of human DNA vaccines.

  2012cites this paper
• Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration.

  2011cites this paper
• Optimization of the heterologous expression of folate metabolic enzymes of Plasmodium falciparum

  2011cites this paper
• CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax

  2011influential citation
• Genetic Immunization with Plasmid DNA Mediated by Electrotransfer

  2011cites this paper